Search Results 71-80 of 17276 for GLP-1 therapy
New treatment option for early type 1 diabetes. According to a recent study, a new immune-modulating therapy helps slow the rate of islet cell loss for ...
GLP-1 receptor agonists as pharmacological treatment for obesity after spinal cord injury: clinical considerations. Arch Phys Med Rehabil. 2026 Mar 11 [Epub ...
... treatment works better than the current standard therapy. ... 1 trial. Phase 4 trials look at long ... Use of GLP-1, GLP-2, human growth hormone (HGH) ...
... GLP-1s. Latest stories. Mayo Clinic researchers ... August 1, 2025. Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast ...
Study aims and design · Changes in eating behaviors. · Changes in obesity-related hormones — ghrelin, polypeptide YY (PYY) and glucagon-like peptide 1 (GLP-1).
... GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors. Ann Intern ... ATLANTIC DIP: Insulin Therapy for Women With IADPSG-Diagnosed Gestational Diabetes ...
This study is a multi-center, non-randomized, prospective single arm study with type 1 patients with diabetes on insulin pump therapy with Continuous Glucose ...
That could eventually pave the way for clinical trials geared toward exploring the safety and effectiveness of manufactured cells as a treatment for Type 1 ...
It's important for those individuals to ask their health care providers if their current diabetes treatment is still the best one for them. At first, LADA ...
... therapy in people with type 1 diabetes. A Pilot Phase involving up to 7 participants using the study system for 10-14 days will be conducted prior to the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.